evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract
18671,GENE_BACKGROUND,,"SYK encodes spleen tyrosine kinase, a signal transduction kinase that is recruited to cell surface receptors through binding of its SH2 domain and activated by phosphorylation (PMID:7538118). Syk activity is needed for B-cell and lymphatic system development (PMID:7477353,12522250). It is expressed mainly in hematopoietic cells but also in subsets of epithelial cancers regulating tumor invasion (PMID:10963601,17699797, 23609194). Activation of Syk may also be a mechanism of ovarian cancer cell chemo-resistance (PMID:26096845). It participates in signal transduction from the immunglobulin receptor in B-cells (PMID:23335753). Syk can activate Flt3 and is important for leukemia survival (PMID:24525236,19800574). Targeting SYK signaling is a potential therapeutic strategy in lymphoma therapy (PMID:26575169, 23764004). Case reports of translocations involving SYK have been reported in MDS and lymphomas (PMID:11159536,16341044).",,2017-01-18,,6850,SYK,spleen associated tyrosine kinase,False,ENST00000375746,NM_003177.5,p72-Syk,False,19800574,Proteomic and genetic approaches identify Syk as an AML target.,Cancer cell,2018-10-06T20:09:00,16,4,281-94,Hahn CK et al,doi: 10.1016/j.ccr.2009.08.018,,0001-10-06,,23335753,Nonredundant roles of Src-family kinases and Syk in the initiation of B-cell antigen receptor signaling.,"Journal of immunology (Baltimore, Md. : 1950)",2018-02-15T20:13:00,190,4,1807-18,Stepanek O et al,doi: 10.4049/jimmunol.1202401,,2018-02-15T19:50:00,,23764004,SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas.,Cancer cell,2018-06-10T20:13:00,23,6,826-38,Chen L et al,doi: 10.1016/j.ccr.2013.05.002,,0001-06-10,,12522250,Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk.,"Science (New York, N.Y.)",2018-01-10T20:03:00,299,5604,247-51,Abtahian F et al,,,0001-01-10,,26096845,Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.,Cancer cell,2018-07-13T20:15:00,28,True,82-96,Yu Y et al,doi: 10.1016/j.ccell.2015.05.009,,0001-07-13,,11159536,Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12).,Blood,2018-02-15T20:01:00,97,4,1050-5,Kuno Y et al,,,0001-02-15,,7538118,Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Ig alpha/Ig beta immunoreceptor tyrosine activation motif binding and autophosphorylation.,The Journal of biological chemistry,0001-05-12,270,19,11590-4,Rowley RB et al,,,0001-05-12,,7477353,Syk tyrosine kinase required for mouse viability and B-cell development.,Nature,0001-11-16,378,6554,303-6,Cheng AM et al,,,0001-11-16,,24525236,SYK is a critical regulator of FLT3 in acute myeloid leukemia.,Cancer cell,2018-02-10T20:14:00,25,2,226-42,Puissant A et al,doi: 10.1016/j.ccr.2014.01.022,,0001-02-10,,23609194,Hypermethylation and prognostic implication of Syk gene in human colorectal cancer.,"Medical oncology (Northwood, London, England)",2013,30,2,586,Yang Z et al,doi: 10.1007/s12032-013-0586-8,,"Yang Z et al. Medical oncology (Northwood, London, England). 2013;30(2)586.",,16341044,Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.,Leukemia,2018-02-01T20:06:00,20,2,313-8,Streubel B et al,,,0001-02-01,,26575169,"Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma.",Oncotarget,2017-12-22T20:15:00,6,41,43881-96,Ma J et al,doi: 10.18632/oncotarget.6316,,0001-12-22,,17699797,Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.,Cancer research,2018-08-15T20:07:00,67,16,7907-16,Luangdilok S et al,,,0001-08-15,,10963601,The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.,Nature,2018-08-17T20:00:00,406,6797,742-7,Coopman PJ et al,,,0001-08-17,
18670,GENE_SUMMARY,,"SYK encodes a tyrosine kinase involved in signal transduction. Upregulation of SYK is found in lymphomas, leukemias and select epithelial tumors.",,2017-01-18,,6850,SYK,spleen associated tyrosine kinase,False,ENST00000375746,NM_003177.5,p72-Syk,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
